Kenya - English - Pharmacy and Poisons Board

martin dow limited plot no. 37, sector 19, korangi industrial area, - tiotropium as bromide monohydrate 18mcg - inhalation powder, hard capsule - tiotropium as bromide monohydrate 18mcg - tiotropium bromide

Australia - English - Department of Health (Therapeutic Goods Administration)

boehringer ingelheim pty ltd - olodaterol hydrochloride, quantity: 2.736 microgram/actuation (equivalent: olodaterol, qty 2.5 microgram/actuation); tiotropium bromide monohydrate, quantity: 3.124 microgram/actuation (equivalent: tiotropium, qty 2.5 microgram/actuation) - inhalation, conventional - excipient ingredients: purified water; benzalkonium chloride; hydrochloric acid; disodium edetate - spiolto respimat is indicated as a once-daily maintenance bronchodilator treatment to relieve symptoms in adult patients with chronic obstructive pulmonary disease (copd).

Australia - English - Department of Health (Therapeutic Goods Administration)

boehringer ingelheim pty ltd - olodaterol hydrochloride, quantity: 2.736 microgram/actuation (equivalent: olodaterol, qty 2.5 microgram/actuation); tiotropium bromide monohydrate, quantity: 3.124 microgram/actuation (equivalent: tiotropium, qty 2.5 microgram/actuation) - inhalation, conventional - excipient ingredients: purified water; benzalkonium chloride; hydrochloric acid; disodium edetate - spiolto respimat is indicated as a once-daily maintenance bronchodilator treatment to relieve symptoms in adult patients with chronic obstructive pulmonary disease (copd).

Canada - English - Health Canada

lupin pharma canada limited - tiotropium (tiotropium bromide monohydrate) - capsule - 18mcg - tiotropium (tiotropium bromide monohydrate) 18mcg

New Zealand - English - Medsafe (Medicines Safety Authority)

boehringer ingelheim (nz) limited - tiotropium bromide monohydrate 22.5ug equivalent 18 µg tiotropium - powder filled inhalation capsule - 18 mcg - active: tiotropium bromide monohydrate 22.5ug equivalent 18 µg tiotropium excipient: gelatin lactose monohydrate - spiriva is indicated for the long term once daily maintenance treatment of bronchospasm and dyspnoea associated with chronic obstructive pulmonary disease (copd), including chronic bronchitis and emphysema. spiriva reduces the frequency of exacerbations and improves exercise tolerance and health-related quality of life.

Australia - English - Department of Health (Therapeutic Goods Administration)

boehringer ingelheim pty ltd - olodaterol hydrochloride, quantity: 2.736 microgram/actuation (equivalent: olodaterol, qty 2.5 microgram/actuation); tiotropium bromide monohydrate, quantity: 3.124 microgram/actuation (equivalent: tiotropium, qty 2.5 microgram/actuation) - inhalation, conventional - excipient ingredients: purified water; benzalkonium chloride; hydrochloric acid; disodium edetate - yanimo respimat is indicated as a once-daily maintenance bronchodilator treatment to relieve symptoms in adult patients with chronic obstructive pulmonary disease (copd).

United States - English - NLM (National Library of Medicine)

physicians total care, inc. - tiotropium bromide monohydrate (unii: l64sxo195n) (tiotropium - unii:0eb439235f) - tiotropium bromide monohydrate 18 ug - spiriva handihaler (tiotropium bromide inhalation powder) is indicated for the long-term, once-daily, maintenance treatment of bronchospasm associated with chronic obstructive pulmonary disease (copd), including chronic bronchitis and emphysema. spiriva handihaler is indicated to reduce exacerbations in copd patients. spiriva handihaler is contraindicated in patients with a hypersensitivity to ipratropium or tiotropium.  in clinical trials and postmarketing experience with spiriva handihaler, immediate hypersensitivity reactions, including angioedema (including swelling of the lips, tongue, or throat), itching, or rash have been reported. teratogenic effects, pregnancy category c. there are no adequate and well-controlled studies in pregnant women.  spiriva handihaler should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. no evidence of structural alterations was observed in rats and rabbits at inhalation tiotropium doses of up to approximately 660 and 6

Australia - English - Department of Health (Therapeutic Goods Administration)

lupin australia pty limited - tiotropium bromide monohydrate, quantity: 22.5 microgram (equivalent: tiotropium, qty 18 microgram) - inhalation, powder for - excipient ingredients: lactose monohydrate - tiotropium powder for inhalation capsule is indicated for long term maintenance treatment of bronchospasm and dyspnoea associated with chronic obstructive pulmonary disease (copd);,prevention of copd exacerbations.

Australia - English - Department of Health (Therapeutic Goods Administration)

lupin australia pty limited - tiotropium bromide monohydrate, quantity: 22.5 microgram (equivalent: tiotropium, qty 18 microgram) - inhalation, powder for - excipient ingredients: lactose monohydrate - tiotropium powder for inhalation capsule is indicated for long term maintenance treatment of bronchospasm and dyspnoea associated with chronic obstructive pulmonary disease (copd);,prevention of copd exacerbations.

Australia - English - Department of Health (Therapeutic Goods Administration)

cipla australia pty ltd - tiotropium bromide monohydrate, quantity: 0.0225 mg (equivalent: tiotropium, qty 0.018 mg) - inhalation, powder for - excipient ingredients: lactose monohydrate - cip tiotropium is indicated for the long term maintenance treatment of bronchospasm and dyspnoea associated with chronic obstructive pulmonary disease (copd). cip tiotropium is indicated for the prevention of copd exacerbations.